Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
NCT02552238
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
174
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
Lumason
Sponsor
Bracco Diagnostics, Inc